ID   DUOX1_RAT               Reviewed;        1551 AA.
AC   Q8CIY2;
DT   21-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   24-JUL-2024, entry version 128.
DE   RecName: Full=Dual oxidase 1;
DE            EC=1.11.1.-;
DE            EC=1.6.3.1;
DE   Flags: Precursor;
GN   Name=Duox1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Fischer 344;
RX   PubMed=12538618; DOI=10.1210/en.2002-220824;
RA   Morand S., Dos Santos O.F., Ohayon R., Kaniewski J., Noel-Hudson M.-S.,
RA   Virion A., Dupuy C.;
RT   "Identification of a truncated dual oxidase 2 (DUOX2) messenger ribonucleic
RT   acid (mRNA) in two rat thyroid cell lines. Insulin and forskolin regulation
RT   of DUOX2 mRNA levels in FRTL-5 cells and porcine thyrocytes.";
RL   Endocrinology 144:567-574(2003).
RN   [2]
RP   TISSUE SPECIFICITY.
RX   PubMed=10806195; DOI=10.1074/jbc.m000916200;
RA   De Deken X., Wang D., Many M.-C., Costagliola S., Libert F., Vassart G.,
RA   Dumont J.E., Miot F.;
RT   "Cloning of two human thyroid cDNAs encoding new members of the NADPH
RT   oxidase family.";
RL   J. Biol. Chem. 275:23227-23233(2000).
CC   -!- FUNCTION: Generates hydrogen peroxide which is required for the
CC       activity of thyroid peroxidase/TPO and lactoperoxidase/LPO. Plays a
CC       role in thyroid hormones synthesis and lactoperoxidase-mediated
CC       antimicrobial defense at the surface of mucosa. May have its own
CC       peroxidase activity through its N-terminal peroxidase-like domain.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADH + O2 = H2O2 + NAD(+); Xref=Rhea:RHEA:11264,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.6.3.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+) + NADPH + O2 = H2O2 + NADP(+); Xref=Rhea:RHEA:11260,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16240,
CC         ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.6.3.1;
CC   -!- ACTIVITY REGULATION: The NADPH oxidase activity is calcium-dependent.
CC       Peroxidase activity is inhibited by aminobenzohydrazide (By
CC       similarity). {ECO:0000250}.
CC   -!- PATHWAY: Hormone biosynthesis; thyroid hormone biosynthesis.
CC   -!- SUBUNIT: Interacts with TXNDC11, TPO and CYBA. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane {ECO:0000250}; Multi-pass
CC       membrane protein {ECO:0000250}. Note=Localizes to the apical membrane
CC       of epithelial cells. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed in thyrocytes (at protein level).
CC       {ECO:0000269|PubMed:10806195}.
CC   -!- PTM: N-glycosylated. {ECO:0000250}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the peroxidase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF542180; AAN33120.1; -; mRNA.
DR   RefSeq; NP_714961.1; NM_153739.1.
DR   AlphaFoldDB; Q8CIY2; -.
DR   SMR; Q8CIY2; -.
DR   STRING; 10116.ENSRNOP00000045928; -.
DR   PeroxiBase; 3970; RnoDuOx01.
DR   GlyCosmos; Q8CIY2; 5 sites, No reported glycans.
DR   GlyGen; Q8CIY2; 5 sites.
DR   PhosphoSitePlus; Q8CIY2; -.
DR   PaxDb; 10116-ENSRNOP00000045928; -.
DR   GeneID; 266807; -.
DR   KEGG; rno:266807; -.
DR   UCSC; RGD:628760; rat.
DR   AGR; RGD:628760; -.
DR   CTD; 53905; -.
DR   RGD; 628760; Duox1.
DR   eggNOG; KOG0039; Eukaryota.
DR   InParanoid; Q8CIY2; -.
DR   OrthoDB; 367877at2759; -.
DR   PhylomeDB; Q8CIY2; -.
DR   Reactome; R-RNO-209968; Thyroxine biosynthesis.
DR   UniPathway; UPA00194; -.
DR   PRO; PR:Q8CIY2; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031252; C:cell leading edge; ISO:RGD.
DR   GO; GO:0009986; C:cell surface; ISO:RGD.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0043020; C:NADPH oxidase complex; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0020037; F:heme binding; IEA:InterPro.
DR   GO; GO:0106293; F:NADH oxidase H202-forming activity; IEA:RHEA.
DR   GO; GO:0106294; F:NADPH oxidase H202-forming activity; IEA:RHEA.
DR   GO; GO:0004601; F:peroxidase activity; IEA:UniProtKB-KW.
DR   GO; GO:0016175; F:superoxide-generating NAD(P)H oxidase activity; IBA:GO_Central.
DR   GO; GO:0042335; P:cuticle development; ISS:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006952; P:defense response; IBA:GO_Central.
DR   GO; GO:0042446; P:hormone biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0050665; P:hydrogen peroxide biosynthetic process; ISO:RGD.
DR   GO; GO:0042744; P:hydrogen peroxide catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:2000147; P:positive regulation of cell motility; ISO:RGD.
DR   GO; GO:0090303; P:positive regulation of wound healing; ISO:RGD.
DR   GO; GO:0072593; P:reactive oxygen species metabolic process; ISO:RGD.
DR   GO; GO:0051591; P:response to cAMP; ISS:UniProtKB.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:InterPro.
DR   GO; GO:0042554; P:superoxide anion generation; IBA:GO_Central.
DR   GO; GO:0006590; P:thyroid hormone generation; IEA:UniProtKB-UniPathway.
DR   CDD; cd09820; dual_peroxidase_like; 1.
DR   CDD; cd00051; EFh; 2.
DR   CDD; cd06186; NOX_Duox_like_FAD_NADP; 1.
DR   Gene3D; 1.10.238.10; EF-hand; 1.
DR   Gene3D; 1.10.640.10; Haem peroxidase domain superfamily, animal type; 1.
DR   Gene3D; 3.40.50.80; Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module; 1.
DR   Gene3D; 2.40.30.10; Translation factors; 1.
DR   InterPro; IPR034821; DUOX_peroxidase.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR013112; FAD-bd_8.
DR   InterPro; IPR017927; FAD-bd_FR_type.
DR   InterPro; IPR013130; Fe3_Rdtase_TM_dom.
DR   InterPro; IPR013121; Fe_red_NAD-bd_6.
DR   InterPro; IPR039261; FNR_nucleotide-bd.
DR   InterPro; IPR019791; Haem_peroxidase_animal.
DR   InterPro; IPR010255; Haem_peroxidase_sf.
DR   InterPro; IPR037120; Haem_peroxidase_sf_animal.
DR   InterPro; IPR050369; RBOH/FRE.
DR   InterPro; IPR017938; Riboflavin_synthase-like_b-brl.
DR   PANTHER; PTHR11972:SF75; DUAL OXIDASE 1; 1.
DR   PANTHER; PTHR11972; NADPH OXIDASE; 1.
DR   Pfam; PF03098; An_peroxidase; 1.
DR   Pfam; PF00036; EF-hand_1; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   Pfam; PF08022; FAD_binding_8; 1.
DR   Pfam; PF01794; Ferric_reduct; 1.
DR   Pfam; PF08030; NAD_binding_6; 1.
DR   PRINTS; PR00457; ANPEROXIDASE.
DR   SFLD; SFLDS00052; Ferric_Reductase_Domain; 1.
DR   SFLD; SFLDG01168; Ferric_reductase_subgroup_(FRE; 1.
DR   SFLD; SFLDG01169; NADPH_oxidase_subgroup_(NOX); 1.
DR   SMART; SM00054; EFh; 2.
DR   SUPFAM; SSF47473; EF-hand; 1.
DR   SUPFAM; SSF52343; Ferredoxin reductase-like, C-terminal NADP-linked domain; 1.
DR   SUPFAM; SSF48113; Heme-dependent peroxidases; 1.
DR   SUPFAM; SSF63380; Riboflavin synthase domain-like; 1.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 3.
DR   PROSITE; PS51384; FAD_FR; 1.
DR   PROSITE; PS50292; PEROXIDASE_3; 1.
PE   1: Evidence at protein level;
KW   Calcium; Cell membrane; FAD; Flavoprotein; Glycoprotein; Hydrogen peroxide;
KW   Membrane; Metal-binding; NADP; Oxidoreductase; Peroxidase;
KW   Reference proteome; Repeat; Signal; Thyroid hormones biosynthesis;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..1551
FT                   /note="Dual oxidase 1"
FT                   /id="PRO_0000223346"
FT   TOPO_DOM        22..596
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        597..617
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        618..1044
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1045..1065
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1066..1080
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1081..1101
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1102..1136
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1137..1157
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1158..1188
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1189..1209
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1210..1226
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1227..1247
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1248
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        1249..1269
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        1270..1551
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          815..850
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          851..886
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          895..930
FT                   /note="EF-hand 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          1087..1269
FT                   /note="Ferric oxidoreductase"
FT   DOMAIN          1270..1376
FT                   /note="FAD-binding FR-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00716"
FT   REGION          26..593
FT                   /note="Peroxidase-like; mediates peroxidase activity"
FT                   /evidence="ECO:0000250"
FT   REGION          956..1248
FT                   /note="Interaction with TXNDC11"
FT                   /evidence="ECO:0000250"
FT   BINDING         828
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         830
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         832
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         834
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         839
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         864
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         866
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         868
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   BINDING         875
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   CARBOHYD        94
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        342
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        354
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        461
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        534
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   1551 AA;  177197 MW;  52B07F83EF4E1FE2 CRC64;
     MAVYSAVAWI LLFGVLASLG AQNPVSWEVQ RFDGWYNNLM EHRWGSKGSR LQRLVPASYA
     DGVYQPLREP YLPNPRHLSN RVMRGPAGQP SLRNRTVLGV FFGYHVLSDL VSVETPGCPA
     EFLNIYIPRG DPVFDPDKRG NVVLPFQRSR WDRSTGQSPS NPRDLTNQVT GWLDGSAIYG
     SSHSWSDTLR SFSGGQLASG PDPAFPRNSQ NSLLMWMAPD PATGQGGPQG LYAFGAQRGN
     REPFLQALGL LWFRYHNLCA KRLAQEHPHW GDEELFQHAR KRVIATYQNI AMYEWLPSFL
     KQTPPEYPGY HPFLDPSISP EFVVASEQFL STMVPPGVYM RNASCHFQGI ANRNSSVSGA
     LRVCNSYWSR ENPKLQRAED VDALLLGMAS QIAEREDHLV VEDVQDFWPG PLKFSRTDYL
     ASCLQRGRDL GLPSYTKARE ALGLPPVSHW QDINPALSRS NGTVLEATAA LYNQDLSRLE
     LLAGGLLESH GDPGPLFSAI VLDQFVRLRD GDRYWFENNR NGLFSKEEIA EIRNTSLRDI
     LVAVTNVDPS ALQPSVFFWL AGDPCPQPSQ LSTQGLPACA PLFVRDYFKG SGFGFGLTIG
     TLCCFPLVSL LSAWIVARLR MRNFKRLQRQ DRQSIMCEKL VGGVEALEWQ GRKEPCRPVL
     VHLQPGQIRV VDGRLTVLRT IQLRPPQQVN LILSSNRGRR TLLLKIPKEY DLVLLFNMEE
     ERQALVENIR AALKENGLSF QEWELREQEL MRAAVTRQQR GHLLETFFRH LFSQVLDINQ
     ADAGTLPLDS STKVREALTC ELSRAEFADS LGLKPQDMFV ESMFSLADKD GNGYLSFREF
     LDILVVFMKG SPEEKSRLMF RMYDFDGNGL ISKDEFIRML RSFIEISNNC LSKDQLAEVV
     ESMFRESGFQ DKEELTWEDF HFMLRDHDSD LRFTQLCVKG VEVPEVIKNL CRRASYISQE
     KICPSPRMSA HCARNNTKTA SSPQRLQCPV DTDPPQEIRR RFGKKVTSFQ PLLFTEAHRE
     KFQRSRRHQT VQQFKRFIEN YRRHIGCVAV FYTITGALFL ERAYYYAFAA HHSGITDTTR
     VGIILSRGTA ASISFMFSYI LLTMCRNLIT FLRETFLNRY IPFDAAVDFH RFIASTAIIL
     TVLHSAGHVV NVYLFSISPL SVLSCLFPDL FHDDGSEFPQ KYYWWFFQTV PGLTGVLLLL
     ALAIMYVFAS HHFRRRSFRG FWLTHHLYIF LYILLIIHGS FALIQMPRFH IFFLVPAIIY
     VGDKLVSLSR KKVEISVVKA ELLPSGVTHL RFQRPQGFEY KSGQWVRIAC LALGTTEYHP
     FTLTSAPHED TLSLHIRAAG PWTTRLREIY SPPTGDTCAR YPKLYLDGPF GEGHQEWHKF
     EVSVLVGAGI GVTPFASILK DLVFKSSVSC QVFCKKIYFI WVTRTQRQFE WLADIIREVE
     ENDSRDLVSV HIYITQLAEK FDLRTTMLYI CERHFQKVLN RSLFTGLRSV THFGRPPFEP
     FFNSLQEVHP QVRKIGVFSC GPPGMTKNVE KACQLINKQD RTHFSHHYEN F
//
